Shashank Reddy Cingam, MBBS

Shashank Cingam practices at Ochsner LSU Health - Academic Medical Center in Shreveport, Louisiana, part of Ochsner Health System.

Shashank Cingam's NPI, 1639552870, was assigned on July 7, 2015. Shashank Cingam holds New Mexico license MD2021-0919.

Shashank Cingam's primary practice is Ochsner LSU Health - Academic Medical Center, at 1541 Kings Highway, Shreveport, LA 71130 in Caddo Parish. The practice phone is (318) 675-5058.

Shashank Cingam's primary practice is Ochsner LSU Health - Academic Medical Center in Shreveport, Louisiana, part of Ochsner Health System. Shashank Cingam is also affiliated with Willis Knighton North. The medical group on file is LSU Health Shreveport. Dmand AI also links Shashank Cingam to 2 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Shashank Cingam practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Shashank Cingam's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Shashank Cingam is licensed in New Mexico.

Dmand AI lists chronic anemia, lymphoma and multiple myeloma among the conditions Shashank Cingam treats.

CMS data shows 494 Medicare services from Shashank Cingam across 4 procedure codes in 2024, for 118 Medicare patients. Medicare paid $43,529 for them. Every service was in an office.

CMS counts 118 Medicare patients who saw Shashank Cingam in 2024. The largest group is 65 to 74, with 67 patients. 70% of them have high blood pressure, and 59% have high cholesterol. 20% are also on Medicaid. Their average risk score is 1.96, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Shashank Cingam's median patient age at 69, with 52% women.

In 2024, Shashank Cingam wrote 223 Medicare Part D claims for 50 patients. 88% of them were for generic drugs. CMS names the drug for 133 of them, across 7 drugs with 11 or more claims each, at $628,167 in total drug cost. In 2023, CMS named 81 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Shashank Cingam for performance year 2024, reported as part of a group. Shashank Cingam accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 5 papers to Shashank Cingam in 2017. 2017 was the busiest year, with 3. The most frequent topics are Diagnosis, Differential. Shashank Cingam has published most often in BMJ Case Rep. Shashank Cingam's most frequent co-authors are Prakash Peddi, MD, Majd Al Shaarani, MD and Kartik Anand, MD.

CMS Open Payments shows 47 general payments to Shashank Cingam from 23 drug and device companies from 2019 to 2025. Consulting fees make up the largest share, 44% of the total. Janssen Pharmaceuticals, Inc paid the most, $3,040.

Shashank Cingam is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.